| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $55.5M | — | +6.0% |
| Cost of Revenue | $22.8M | — | -3.4% |
| Gross Profit | $32.7M | — | +13.6% |
| R&D Expense | $2.3M | — | +3.8% |
| SG&A Expense | $5.2M | — | +92.8% |
| Operating Income | $25.1M | — | +5.4% |
| Pre-tax Income | $27.6M | — | +14.0% |
| Income Tax | $7.2M | — | +15.0% |
| Net Income | $20.4M | — | +13.7% |
| EPS (Basic) | $0.22 | — | +0.0% |
| EPS (Diluted) | $0.22 | — | +0.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $231.4M | -24.2% | — |
| Accounts Receivable | $2.5M | -13.5% | — |
| Current Assets | $260.9M | -19.9% | — |
| Total Assets | $379.8M | +9.2% | — |
| Current Liabilities | $98.6M | +16.8% | — |
| Total Liabilities | $104.8M | +12.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $25.5M | — | +28.8% |
| Investing Cash Flow | -$99.3M | — | — |
| Financing Cash Flow | -$57K | — | — |
| — |
| Stockholders' Equity | $274.9M | +8.2% | +704.3% |